Considering that immune cells are an important component of the tumour environment, glioma‐derived exosomes would deliver CT62, DPY19L2P1, and KCNH1‐IT1 to immune cells, regulating the tumour immune microenvironment.59, 60. This evidence concerns the gene CT62 and central nervous system cancer.